The Bid

The Covid-19 pandemic has put genomics and immunology front and center. On the first episode of a five-part mini-series on megatrends, CEO of Moderna Stéphane Bancel and CEO of CRISPR Therapeutics Dr. Samarth Kulkarni share their perspectives as companies on the frontlines.First, Stéphane shares how Moderna innovated to produce a Covid-19 vaccine in record time and the potential of mRNA technology. Then, Samarth discusses how the medical breakthroughs of CRISPR technology will impact other medical crises like cancer and sickle cell disease in years to come.This material is for informational purposes and is prepared by BlackRock, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. The information and opinions contained in this material are derived from proprietary and nonproprietary sourc